Cargando…

TP53 and MDM2 Gene Polymorphisms, Gene-Gene Interaction, and Hepatocellular Carcinoma Risk: Evidence from an Updated Meta-Analysis

BACKGROUND: The association between TP53 R72P and/or MDM2 SNP309 polymorphisms and hepatocellular carcinoma (HCC) risk has been widely reported, but results were inconsistent. To clarify the effects of these polymorphisms on HCC risk, an updated meta-analysis of all available studies was conducted....

Descripción completa

Detalles Bibliográficos
Autores principales:	Peng, Qiliu, Lao, Xianjun, Chen, Zhiping, Lai, Hao, Deng, Yan, Wang, Jian, Mo, Cuiju, Sui, Jingzhe, Wu, Junrong, Zhai, Limin, Yang, Shi, Qin, Xue, Li, Shan
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2013
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3871586/ https://www.ncbi.nlm.nih.gov/pubmed/24376578 http://dx.doi.org/10.1371/journal.pone.0082773

Ejemplares similares

An Updated Meta-Analysis on the Association of MDM2 SNP309 Polymorphism with Colorectal Cancer Risk
por: Qin, Xue, et al.
Publicado: (2013)

MDM2 SNP309 polymorphism contributes to endometrial cancer susceptibility: evidence from a meta-analysis
por: Peng, Qiliu, et al.
Publicado: (2013)

The NQO1 Pro187Ser polymorphism and breast cancer susceptibility: evidence from an updated meta-analysis
por: Peng, Qiliu, et al.
Publicado: (2014)

TP53 and MDM2 gene polymorphisms and risk of hepatocellular carcinoma among Italian patients
por: Di Vuolo, Valeria, et al.
Publicado: (2011)

Glutathione S-transferase gene GSTM1, gene-gene interaction, and gastric cancer susceptibility: evidence from an updated meta-analysis
por: Lao, Xianjun, et al.
Publicado: (2014)

Current evidences on XPC polymorphisms and gastric cancer susceptibility: a meta-analysis
por: Peng, Qiliu, et al.
Publicado: (2014)

Association of Single Nucleotide Polymorphisms in VDR and DBP Genes with HBV-Related Hepatocellular Carcinoma Risk in a Chinese Population
por: Peng, Qiliu, et al.
Publicado: (2014)

Association between OGG1 Ser326Cys and APEX1 Asp148Glu polymorphisms and breast cancer risk: a meta-analysis
por: Peng, Qiliu, et al.
Publicado: (2014)

Polymorphisms in MDM2 and TP53 Genes and Risk of Developing Therapy-Related Myeloid Neoplasms
por: Cabezas, Maria, et al.
Publicado: (2019)

Lack of association between cathepsin D C224T polymorphism and Alzheimer’s disease risk: an update meta-analysis
por: Mo, Cuiju, et al.
Publicado: (2014)

Meta-Analysis of the Association between COX-2 Polymorphisms and Risk of Colorectal Cancer Based on Case–Control Studies
por: Peng, Qiliu, et al.
Publicado: (2014)

Individual and combined effect of TP53, MDM2, MDM4, MTHFR, CCR5, and CASP8 gene polymorphisms in lung cancer
por: Stumbryte, Ausra, et al.
Publicado: (2017)

Genetic polymorphisms of MDM2 and TP53 genes are associated with risk of nasopharyngeal carcinoma in a Chinese population
por: Xiao, Mang, et al.
Publicado: (2010)

Expression signature based on TP53 target genes doesn't predict response to TP53-MDM2 inhibitor in wild type TP53 tumors
por: Sonkin, Dmitriy
Publicado: (2015)

Effects of MDM2, MDM4 and TP53 Codon 72 Polymorphisms on Cancer Risk in a Cohort Study of Carriers of TP53 Germline Mutations
por: Fang, Shenying, et al.
Publicado: (2010)

Association Between XPD Lys751Gln and Asp312Asn Polymorphisms and Hepatocellular Carcinoma Risk: A Systematic Review And Meta-Analysis
por: Peng, Qiliu, et al.
Publicado: (2014)

MDM4 expression as an indicator of TP53 reactivation by combined targeting of MDM2 and MDM4 in cancer cells without TP53 mutation
por: Hirose, Mitsuaki, et al.
Publicado: (2014)

TP53 and MDM2 polymorphisms and the risk of endometrial cancer in postmenopausal women
por: Zając, Agnieszka, et al.
Publicado: (2014)

Uncommon non-oncogenic HPV genotypes, TP53 and MDM2 genes polymorphisms in HIV-infected women in Southern Brazil
por: Entiauspe, Ludmila Gonçalves, et al.
Publicado: (2014)

DNA Repair Gene XRCC1 Polymorphisms, Smoking, and Bladder Cancer Risk: A Meta-Analysis
por: Li, Shan, et al.
Publicado: (2013)

The Association of Common Functional Polymorphisms in Mir-146a and Mir-196a2 and Hepatocellular Carcinoma Risk: Evidence from a Meta-Analysis
por: Peng, Qiliu, et al.
Publicado: (2014)

Impact on breast cancer susceptibility and clinicopathological traits of common genetic polymorphisms in TP53, MDM2 and ATM genes in Sardinian women
por: Floris, Matteo, et al.
Publicado: (2022)

Cell Surface Glycan Alterations in Epithelial Mesenchymal Transition Process of Huh7 Hepatocellular Carcinoma Cell
por: Li, Shan, et al.
Publicado: (2013)

The cell cycle regulatory gene polymorphisms TP53 (rs1042522) and MDM2 (rs2279744) in lung cancer: a meta-analysis
por: Bulgakova, O., et al.
Publicado: (2020)

Investigation of ATM, TP53 and MDM2 polymorphisms and their association with outcome of radiotherapy for prostate cancer
por: Cintra, Hellen S, et al.
Publicado: (2013)

The association of polymorphic markers Arg399Gln of XRCC1 gene, Arg72Pro of TP53 gene and T309G of MDM2 gene with breast cancer in Kyrgyz females
por: Isakova, Jainagul, et al.
Publicado: (2017)

The Association between MTHFR Gene Polymorphisms and Hepatocellular Carcinoma Risk: A Meta-Analysis
por: Qin, Xue, et al.
Publicado: (2013)

TP53 and TP53-associated genes are correlated with the prognosis of paediatric neuroblastoma
por: Wang, Haiwei, et al.
Publicado: (2022)

Impact of TP53 Codon 72 and MDM2 SNP 309 Polymorphisms in Pancreatic Ductal Adenocarcinoma
por: Hori, Yasuki, et al.
Publicado: (2015)

Alcohol dehydrogenase 4 is a TP53-associated gene signature for the prediction of prognosis in hepatocellular carcinoma
por: Zhang, Yuan, et al.
Publicado: (2022)

XPC Lys939Gln polymorphism contributes to colorectal cancer susceptibility: evidence from a meta-analysis
por: Peng, Qiliu, et al.
Publicado: (2014)

Association of TP53 gene codon 72 polymorphism with endometriosis risk in Isfahan
por: Nikbakht Dastjerdi, Mehdi, et al.
Publicado: (2013)

EGF +61A/G polymorphism contributes to increased gastric cancer risk: evidence from a meta-analysis
por: Peng, Qiliu, et al.
Publicado: (2014)

Joint association of polymorphism of the FGFR4 gene and mutation TP53 gene with bladder cancer prognosis
por: Yang, Y C, et al.
Publicado: (2006)

Association of MDM2 SNP309 and TP53 Arg72Pro polymorphisms with risk of endometrial cancer
por: YONEDA, TOMOKO, et al.
Publicado: (2013)

Correction: Impact of TP53 Codon 72 and MDM2 SNP 309 Polymorphisms in Pancreatic Ductal Adenocarcinoma
Publicado: (2015)

Low Prevalence of TP53 Mutations and MDM2 Amplifications in Pediatric Rhabdomyosarcoma
por: Ognjanovic, Simona, et al.
Publicado: (2012)

Study of polymorphisms in the TP53 and RB1 genes in children with retinoblastoma in northern Mexico
por: Anaya-Pava, Edwin J., et al.
Publicado: (2017)

TP53 and MDM2 single nucleotide polymorphisms influence survival in non-del(5q) myelodysplastic syndromes
por: McGraw, Kathy L., et al.
Publicado: (2015)

Updates from the TP53 universe
por: Pentimalli, Francesca
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_1bij7vp6tb2o0escmdnhna7d7b